HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William L Stone Selected Research

2-chloroethyl ethyl sulfide

3/2011Sodium pyruvate modulates cell death pathways in HaCaT keratinocytes exposed to half-mustard gas.
1/2011Protective effect of liposome-encapsulated glutathione in a human epidermal model exposed to a mustard gas analog.
5/2010Antioxidant liposomes protect against CEES-induced lung injury by decreasing SAF-1/MAZ-mediated inflammation in the guinea pig lung.
7/2009Role of MAPK/AP-1 signaling pathway in the protection of CEES-induced lung injury by antioxidant liposome.
3/2009Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes.
6/2008The influence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue.
11/2006Inhibition of inducible Nitric Oxide Synthase by a mustard gas analog in murine macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William L Stone Research Topics

Disease

6Neoplasms (Cancer)
01/2017 - 10/2003
6Prostatic Neoplasms (Prostate Cancer)
04/2015 - 05/2008
5Colonic Neoplasms (Colon Cancer)
03/2014 - 01/2002
5Inflammation (Inflammations)
03/2011 - 11/2006
3Lung Injury
05/2010 - 03/2009
1COVID-19
09/2020
1Neonatal Abstinence Syndrome
01/2020
1Pediatric Obesity
01/2016
1Obesity
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
03/2014
1Necrosis
03/2011
1Wounds and Injuries (Trauma)
06/2008
1Coinfection
06/2008
1Cardiovascular Diseases (Cardiovascular Disease)
05/2008

Drug/Important Bio-Agent (IBA)

72-chloroethyl ethyl sulfideIBA
03/2011 - 11/2006
6AntioxidantsIBA
09/2014 - 12/2004
4Tocopherols (Tocopherol)IBA
05/2011 - 10/2003
4Mustard Gas (Sulfur Mustard)IBA
01/2011 - 03/2009
4Vitamin EFDA LinkGeneric
03/2009 - 10/2003
3Biomarkers (Surrogate Marker)IBA
01/2016 - 06/2012
3Proteins (Proteins, Gene)FDA Link
09/2014 - 10/2003
3Protein Isoforms (Isoforms)IBA
05/2011 - 10/2003
3Liposomes (Liposome)IBA
05/2010 - 03/2009
3gamma-TocopherolIBA
01/2006 - 01/2002
2EstersIBA
09/2014 - 02/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 03/2014
2ProdrugsIBA
09/2014 - 02/2014
2EsterasesIBA
09/2014 - 02/2014
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2011 - 10/2003
1Phospholipids (Phosphatides)FDA LinkGeneric
09/2020
1Chloroquine (Aralen)FDA LinkGeneric
09/2020
1Protons (Proton)IBA
09/2020
1Heme (Haem)IBA
09/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2020
1nasIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2017
1AndrogensIBA
04/2015
1Diphosphonates (Bisphosphonates)IBA
04/2015
1Mevalonic Acid (Mevalonate)IBA
04/2015
1TransferasesIBA
04/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2015
1Alendronate (Alendronate Sodium)FDA LinkGeneric
04/2015
1Simvastatin (Zocor)FDA LinkGeneric
04/2015
1Peptide Hydrolases (Proteases)FDA Link
09/2014
1serine esteraseIBA
09/2014
1HydrolasesIBA
02/2014
1polyacrylamideIBA
02/2014
1naphthyl acetateIBA
02/2014
1Fast Blue RR saltIBA
02/2014
1Carboxylesterase (Hydrolase S)IBA
06/2012
1TocotrienolsIBA
05/2011
1Pyruvic Acid (Pyruvate)IBA
03/2011
1SodiumIBA
03/2011
1Alkylating AgentsIBA
01/2011
1Mitogen-Activated Protein KinasesIBA
05/2010
1Transcription Factors (Transcription Factor)IBA
05/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010
1Syntex adjuvant formulationIBA
05/2010
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2010
1AntidotesIBA
03/2009
1Polymyxin B (Aerosporin)FDA LinkGeneric
06/2008
1Anti-Bacterial Agents (Antibiotics)IBA
06/2008
1Therapeutic UsesIBA
06/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2006
1alpha-TocopherolFDA Link
01/2006
1MutagensIBA
12/2004
1LipidsIBA
12/2004
1Free RadicalsIBA
12/2004
1PPAR gammaIBA
10/2003
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2003
1Nitrogen DioxideIBA
10/2003
1Messenger RNA (mRNA)IBA
10/2003
1LigandsIBA
10/2003

Therapy/Procedure

1Chemoprevention
10/2003